Mark E. Obrenovich
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
- Physiology top 2%
- Alzheimer's disease research and treatments
Papers in
- Physiology 30
- Alzheimer's disease research and treatments 28
- Nitric Oxide and Endothelin Effects 5
-
- Advanced Glycation End Products research 10
- Co-authors
- Gjumrakch Aliev (33 shared papers)George Perry (25 shared papers)Mark A. Smith (20 shared papers)Vincent M. Monnier (11 shared papers)V. Prakash Reddy (11 shared papers)Hector H. Palacios (15 shared papers)Craig Atwood (5 shared papers)Frédéric Jacques Tessier (1 shared paper)
- Journals
- Science of Aging Knowledge Environment (4 papers)Alzheimer s & Dementia (4 papers)CNS & Neurological Disorders - Drug Targets (4 papers)Neurotoxicity Research (4 papers)Neurological Research (2 papers)
- Partner nations
- United StatesAzerbaijanColombia
In The Last Decade
Mark E. Obrenovich
79 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 119
- Clinical Biochemistry 366
- Physiology 1.1k
- Aging 67
- Biochemistry 262
- Neurology 233
Countries citing papers authored by Mark E. Obrenovich
This map shows the geographic impact of Mark E. Obrenovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Obrenovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Obrenovich more than expected).
Fields of papers citing papers by Mark E. Obrenovich
This network shows the impact of papers produced by Mark E. Obrenovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Obrenovich. The network helps show where Mark E. Obrenovich may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Obrenovich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 328 | |
| 2 | 2003 | 259 | |
| 3 | 2018 | 217 | |
| 4 | 1999 | 163 | |
| 5 | 2003 | 155 | |
| 6 | 2008 | 143 | |
| 7 | 2003 | 125 | |
| 8 | 2010 | 119 | |
| 9 | 2008 | 115 | |
| 10 | 2011 | 109 | |
| 11 | 2020 | 100 | |
| 12 | 2006 | 98 | |
| 13 | 2009 | 96 | |
| 14 | 2002 | 93 | |
| 15 | 2009 | 92 | |
| 16 | 2003 | 85 | |
| 17 | 2009 | 83 | |
| 18 | 1999 | 76 | |
| 19 | 2006 | 68 | |
| 20 | Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. | 2000 | 63 |
About Mark E. Obrenovich
Mark E. Obrenovich is a scholar working on Physiology, Clinical Biochemistry, Neurology, Molecular Biology and Biochemistry, having authored 82 papers that have together received 3.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (28 papers), Gut microbiota and health (16 papers), Advanced Glycation End Products research (10 papers), Neurological Disease Mechanisms and Treatments (8 papers), Mitochondrial Function and Pathology (8 papers), Nitric Oxide and Endothelin Effects (5 papers), Phytochemicals and Antioxidant Activities (4 papers) and Dementia and Cognitive Impairment Research (4 papers). The work is most often cited by research in Clinical Biochemistry (366 citations), Physiology (1.1k citations), Aging (67 citations), Biochemistry (262 citations) and Neurology (233 citations). Mark E. Obrenovich has collaborated with scholars based in United States, Azerbaijan and Colombia. Frequent co-authors include Gjumrakch Aliev, George Perry, Mark A. Smith, Vincent M. Monnier, V. Prakash Reddy, Hector H. Palacios, Craig Atwood, Frédéric Jacques Tessier, Akihiko Nunomura and Rudolph J. Castellani. Their work appears in journals such as Science of Aging Knowledge Environment, Alzheimer s & Dementia, CNS & Neurological Disorders - Drug Targets, Neurotoxicity Research and Neurological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.